DNAH8 and gastroesophageal reflux disease: Omeprazole is an established therapy for GERD and belongs to the class of anti-secretory PPIs, which are substituted benzimidazole derivatives that selectively and irreversibly inhibit the H+/K+ adenosine triphosphatase (ATPase) enzyme system at the secretory surface of parietal cells[26,27].